BioNTech ist ein Biotechunternehmen, das sich auf die Entwicklung von Immuntherapien zur Behandlung von Krebs und anderen schweren Krankheiten spezialisiert hat. Der Firmensitz befindet sich in Mainz, der Börsengang erfolgte im Oktober 2019 an der Nasdaq.
COMPANY
INVESTOR TERMSHEET
22UA

BioNTech
#BGFL Mood: - · #BGFL-Indicator: - · Review date: -
LEI: 894500UZJ5LG1F8J1U58
SECTOR: Gesundheit SUB-SECTOR: Biotechnologie
NAME
BioNTech
WKN
A2PSR2
ISIN
US09075V1026
TICKER
22UA
INDEX
EXCHANGE
Xetra
Made with ❤ von BGFL

EARNINGS PER SHARE (Visualized)

The visualised presentation of the long-term development of earnings per share gives investors a quick overview of the fluctuation range of the profits or losses achieved. Where estimates are still involved, these originate from boersengefluester.de (BGFL).

EARNINGS PER SHARE (in numbers)

2016 2017 2018 2019 2020 2021 2022 2023 2024e 2025e
0,00 0,00 -0,21 -0,85 0,06 39,63 37,77 3,83 -1,80 -1,45
- +0,00 +0,00 -0,64 +0,91 +39,57 -1,86 -33,94 -5,63 -5,28
- +0,00% +0,00% +304,76% +107,06% +65.950,00% -4,69% -89,86% -147,00% -137,86%

Earnings per share are earnings after tax (adjusted for minority interests) divided by the number of shares issued. Earnings per share (EpS) are used in particular to calculate the price/earnings ratio, or P/E ratio for short.

The decisive factor for the valuation of most companies is what profits are generated in the end. Accordingly, the price/earnings ratio (P/E ratio) is still the most popular key figure for investors. Here we show a selection of apps for which earnings per share play a central role.

Advertising is an important revenue channel for us. But we understand, that sometimes it becomes annoying. If you want to reduce the number of shown ADs just simply login to your useraccount and manage the settings from there. As registered user you get even more benefits.
          Qualitätsjournalismus · Made in Germany © 2024          
The news manufactory

Good luck with all your investments

Founded in 2013 by Gereon Kruse, the financial portal boersengefluester.de is all about German shares - with a clear focus on second-line stocks. In addition to traditional editorial articles, the site stands out in particular thanks to a large number of self-developed analysis tools. All tools are based on a completely self-maintained database for more than 650 shares. As a result, boersengefluester.de produces Germany's largest profit and dividend forecast.

Contact

Idea & concept: 3R Technologies   
boersengefluester.de GmbH Copyright © 2024 by Gereon Kruse #BGFL